Please login or sign up to post and edit reviews.
78. Batterytech, VCs, SPACs: “There will be blood” - jul22
Media Type |
audio
Podknife tags |
Business
Energy
Technology
Categories Via RSS |
Business
Publication Date |
Jul 15, 2022
Episode Duration |
00:27:21
The future of storage is so bright that investing in in the vertical and its adjacencies is the opportunity of a lifetime. At the same time, buyer beware - there are many Theranos-like investment opportunities lurking out there in our vertical. You've got to be very smart to minimize the losers in your portfolio…or, as the great Michael Lewis would say, adopt a “Moneyball” approach.Where are the successes and where are the pitfalls? You need to be a great financier but also a fantastic scientist to figure out which will be the winning opportunities in the maze of projects floating around.That’s why we have invited Jeff Chamberlain, CEO of Volta Energy Technologies (a 400mUSD Venture Capital fund) to discuss all the new innovations out there, including solid-state batteries. Jeff Chamberlain launched Volta Energy Technologies (https://volta.vc/ ) from Argonne National Laboratory in 2016. Volta’s investment scope includes batteries, storage, and all the associated technology required to reduce cost and integrate batteries into vehicles and the grid across a spectrum of innovation that includes materials production, batteries, fast-charge tech, power electronics, management software, and recycling. Jeff and his team leverage all their knowledge and experience not only in batteries but also more generally in technology commercialization, physics, engineering, and investing to source, diligence, underwrite, and manage their investments.We talk about the difficulties of scaling and the need to integrate innovations into the current industrial infrastructure and supply chains, not try to compete against them. The debate doesn’t not avoid “controversial” companies such as Quantum Scape and Energy Vault. In conclusion, Batterytech is a fantastic field of investing, but there are Zombies out there, not only in VCs but also in public markets under the form of SPACs. There will be blood.A great thanks to our partner Aquila Capital

This episode currently has no reviews.

Submit Review
This episode could use a review!

This episode could use a review! Have anything to say about it? Share your thoughts using the button below.

Submit Review